Show simple item record

dc.contributor.authorMacArtney, John
dc.contributor.authorMalmström, Marlene
dc.contributor.authorNielsen, Trine Overgaard
dc.contributor.authorEvans, Julie
dc.contributor.authorBernhardson, Britt-Marie
dc.contributor.authorHajdarevic, Senada
dc.contributor.authorChapple, Alison
dc.contributor.authorEriksson, Lars E.
dc.contributor.authorLocock, Louise
dc.contributor.authorRasmussen, Birgit
dc.contributor.authorVedsted, Peter
dc.contributor.authorTishelman, Carol
dc.contributor.authorAndersen, Rikke Sand
dc.contributor.authorZiebland, Sue
dc.date.accessioned2017-12-06T17:44:12Z
dc.date.available2017-12-06T17:44:12Z
dc.date.issued2017-11
dc.identifier.citationMacArtney , J , Malmström , M , Nielsen , T O , Evans , J , Bernhardson , B-M , Hajdarevic , S , Chapple , A , Eriksson , L E , Locock , L , Rasmussen , B , Vedsted , P , Tishelman , C , Andersen , R S & Ziebland , S 2017 , ' Patients’ initial steps to cancer diagnosis in Denmark, England and Sweden : what can a qualitative, cross-country comparison of narrative interviews tell us about potentially modifiable factors? ' , BMJ Open , vol. 7 , no. 11 , e018210 , pp. 1-10 . https://doi.org/10.1136/bmjopen-2017-018210en
dc.identifier.issn2044-6055
dc.identifier.otherPURE: 111725930
dc.identifier.otherPURE UUID: 0fc1572e-5aa6-4d1a-9826-4d571f7b702f
dc.identifier.otherScopus: 85045713666
dc.identifier.otherORCID: /0000-0002-8109-1930/work/83704594
dc.identifier.urihttp://hdl.handle.net/2164/9701
dc.descriptionAcknowledgments We wish to thank Professor Mike Richards (then National Cancer Director) and Professor Chris Ham (Chief Executive King’s Fund) who had the original idea for the study as well as facilitated bringing the three research teams together. We are extremely grateful to the people who took part in this research in all three countries, and to the study advisory panel, including patient and public representatives, who helped design the study and provided comments on an earlier draft of this manuscript. We also acknowledge the support of the National Institute for Health Research, through the Clinical Research Network, who helped recruit patients into the English arm of the study. We would also like to thank all those who helped to recruit participants: In England, we would like to thank the NHS Hospital Trusts that assisted with this study and Patients Active in Research; Thames Valley, along with the following charities who posted links or circulated our details on social media; Beating Bowel Cancer, Bowel Cancer UK, Roy Castle Lung Cancer Foundation, British Lung Foundation and healthtalk.org. In Denmark, we want to thank the Lung Cancer Patient organisation, as well as the Colon Cancer Patient organisation for assisting us in recruiting patients. We also wish to thank the local support groups of the National Danish Cancer Society, as well as the local oncology departments in various regions of Denmark. In Sweden, we would like to thank the nurses and physicians who helped with recruitment. Funding This paper presents independent research funded by organisations from three European countries as follows: In the UK, the study was supported by the National Awareness and Early Diagnosis Initiative (NAEDI). The contributing partners include: Cancer Research UK; Department of Health, England; Economic and Social Research Council; Health and Social Care Research and Development Division, Public Health Agency, Northern Ireland; National Institute for Social Care and Health Research, Wales and the Scottish Government. This funding also covered the costs associated with the comparative analysis meetings in Denmark and Sweden and funded translation of the Danish and Swedish material for publications. During the study LL was Director of Applied Research at the Health Experiences Research Group, Nuffield Department of Primary Care Health Sciences, University of Oxford, and was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre and the NIHR Collaboration for Leadership in Applied Health Research and Care Oxford (CLAHRC) at Oxford Health NHS Foundation Trust. In Denmark, the study was supported by the Research Centre for Cancer Diagnosis in Primary Care funded by The Danish Cancer Society and the Novo Nordic Foundation. In Sweden, the study was supported by the Vårdal Foundation; the Strategic Research Program in Care Sciences (SFO-V), Umeå University; the Cancer Research Foundation in Northern Sweden and from government funding of clinical research within the National Health Service, Sweden.en
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofBMJ Openen
dc.rights© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectR Medicineen
dc.subjectNational Institute for Health Research (NIHR)en
dc.subjectCancer Research UKen
dc.subjectEconomic and Social Research Council (ESRC)en
dc.subject.lccRen
dc.titlePatients’ initial steps to cancer diagnosis in Denmark, England and Sweden : what can a qualitative, cross-country comparison of narrative interviews tell us about potentially modifiable factors?en
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Health Services Research Uniten
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1136/bmjopen-2017-018210
dc.identifier.vol7en
dc.identifier.iss11en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record